The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.

NCT04727320 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Tauroursodeoxycholic acid
DRUG: Placebo

Sponsor

The First Affiliated Hospital with Nanjing Medical University